Martin R. Jefson,John A. Lowe, III,Fabian Dey,Andreas Bergmann,Andreas Schoop,Nathan Oliver Fuller
申请号：
US16726990
公开号：
US20200247814A1
申请日:
2019.12.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
